Fibronectin mediates APOE4-driven blood–brain barrier dysfunction in Alzheimer’s disease Sep 11 Written by Fanny Elahi Fanny Elahi Previous Previous Spatial atlas of the human brain vasculature reveals specialized cell ensembles Next Next Rapid plaque clearance with anti-amyloid therapy for Alzheimer’s disease: in consideration of donanemab treatment duration from real-world cases
Fibronectin mediates APOE4-driven blood–brain barrier dysfunction in Alzheimer’s disease Sep 11 Written by Fanny Elahi Fanny Elahi
